Showing results (2051-2060 of 11,098) with videos related to
Sort By:
Pageof 1,110
Journal of Neurology|September 26, 2019
Epidemiology of paraneoplastic neurological syndromes: a population-based studyAlberto Vogrig, Gian Luigi Gigli, Samantha Segatti, et al.Journal of Neurology|September 29, 2019
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumabMonica Margoni, Francesca Rinaldi, Alice Riccardi, et al.Journal of Neurology|January 16, 2021
Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experienceMaxens Decavèle, Aliénor Dreyfus, Nicolas Gatulle, et al.Journal of Neurology|October 2, 2019
Lost or unavailable? Exploring mechanisms that affect retrograde memory in mild cognitive impairment and Alzheimer's disease patientsMaria Stefania De Simone, Massimo De Tollis, Lucia Fadda, et al.Journal of Neurology|October 5, 2019
Clinical features distinguish cerebral amyloid angiopathy-associated convexity subarachnoid haemorrhage from suspected TIAJoel Elliot Dane Stanton, Arvind Chandratheva, Duncan Wilson, et al.Journal of Neurology|September 11, 2019
How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational studyCarlo Colosimo, David Charles, Vijay P Misra, et al.Journal of Neurology|September 12, 2019
Interaction between the heart and the brain in transient global amnesiaPhilipp Eisele, Stefan Baumann, Laila Noor, et al.Journal of Neurology|September 15, 2019
Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patientsCarl Moritz Zipser, Jeremy Deuel, Jutta Ernst, et al.Journal of Neurology|January 21, 2021
Adjunctive steroids in adults with encephalitis: a propensity score analysisAmbreen Allana, Mohammed Samannodi, Michael A Hansen, et al.Journal of Neurology|January 21, 2021
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosisMalin Boremalm, Peter Sundström, Jonatan SalzerPageof 1,110